Search Login Register

Triazolam (Halcion) Summary

Description: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Also Known As: Halcion; Apo-Triazo; Apotex Brand of Triazolam; Gen-Triazolam; Genpharm Brand of Triazolam Show All >>

Networked: 258 relevant articles (21 outcomes, 40 trials/studies) for this Drug

Key Diseases for which Triazolam is Relevant

  1. Sleep Initiation and Maintenance Disorders (Insomnia) : 13 outcomes 20 studies in 88 results
  2. Pain (Aches) : 4 outcomes 1 study in 6 results
  3. Substance-Related Disorders (Drug Abuse) : 1 outcome 7 studies in 15 results
  4. Shock : 1 outcome 2 studies in 9 results
  5. Chronic Obstructive Pulmonary Disease (COPD) : 1 outcome 1 study in 4 results
Show All >>

Drugs Related to Triazolam

  1. Benzodiazepines
  2. Flurazepam (Dalmane)
  3. Temazepam (Nocturne)
  4. zopiclone (Zop)
  5. Diazepam (Valium)
  6. zolpidem (Ambien)
  7. Flunitrazepam (Rohypnol)
  8. Trazodone (Trittico)
  9. zaleplon (Sonata)
  10. Nitrazepam (Serenade)
Show All >>

Therapies Related to Triazolam

  1. Operating Tables
  2. Preoperative Period
  3. Conscious Sedation
  4. Premedication
  5. Hypnosis (Mesmerism)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.